What if male contraception were as simple as getting a flu shot?

The future of male contraception.

Contraline has developed a new contraceptive for men called Echo-V.

It's a polymer gel implanted non-surgically into the vas deferens. The first long-lasting, non-hormonal, and reversible male birth control.

Learn how it works »

"Men want to help female partners out. Times are changing."

Our Mission

The demand for better birth control has never been higher. Contraline aims to provide men with a safe, effective, and appealing contraceptive option.

Meet Our Team

View all team members

Kevin Eisenfrats

Co-Founder and Chief Executive Officer

Kevin Eisenfrats graduated from the University of Virginia with a degree in Nanomedicine Engineering. Having conceived the idea behind Contraline, Mr. Eisenfrats has won numerous university and national awards for the invention. Mr. Eisenfrats spearheads the product development and the business side of Contraline.

Dr. John Herr, Ph.D.

In memory of our Co-Founder

Dr. Herr was a Professor of Cell Biology, Urology, and Biomedical Engineering at the University of Virginia. He was also Director of the Center for Research in Contraceptive and Reproductive Health and renowned expert in reproductive biology. Dr. Herr founded four biotechnology companies before co-founding Contraline.


Contraline Accelerates Growth with Expansion into New Laboratories and Addition of Key Team Members

CHARLOTTESVILLE, Virginia — Earlier this fall, Contraline moved its operations from the University of Virginia School of Medicine into its new headquarters in Charlottesville, called “ContraLab.” ContraLab is a 2200 sq. ft. office and laboratory space located at 1216 Harris Street. The laboratory space will be used primarily for research and product development including synthesizing […]